Delivery Order SPE2DB24D9144-SPE2DB25FCNAH
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device, with a period of performance through January 10, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $3,552.00, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg contraceptive systems to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,552.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order falls under a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The delivery order is for the provision of Mirena 52 mg systems, a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $20,720.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a contraceptive product, with a completion date of June 17, 2024. This award is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,457.28, is for the delivery of Mirena 52 mg systems, a contraceptive product. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, was awarded without set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCNAHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this procurement, allowing DMS Pharmaceutical Group to compete directly in the open market. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The company serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of medications and medical supplies to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's extensive contract portfolio with DLA demonstrates its established capability to reliably deliver both branded and generic pharmaceutical products, including specialty medications, biologics, and medical consumables essential to military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/12/25 |